# Anthim

NDC: 69604-204
Generic name: obiltoxaximab
Labeler / Manufacturer: Elusys Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20160318

FDA application: BLA125509

## Active ingredients

- OBILTOXAXIMAB: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69604-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69604-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39ad8799-00a4-4fc8-9852-c0536350c474